FibroBiologics, Inc. FBLG
0.95 USD -0.04 (-4.01%)
Nov 4, 2026, 11:13 AM EST
0.9501 Day range 1.04
0.62 52-week range 9.60
- YTD
- -78.88%
- 1 year
- -85.47%
Financial health
Altman Z-Score
-16.85 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 5
Valuation
P/E -0.5×
FY 2020 5y median -49.3× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.6×
FY 2020 5y median 1.6× FY 2025
P/FCF -0.6×
FY 2020 5y median -137× FY 2025
EV/EBITDA -0.4×
FY 2020 5y median -59.0× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -165.8%
FY 2020 5y median -0.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -302.9%
FY 2020 5y median -302.9% FY 2025
ROIC -194.4%
FY 2020 5y median -194.4% FY 2025
ROA -193.8%
FY 2020 5y median -139.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -21.2%
FY 2020 FY 2025
EPS (diluted) -22.8%
FY 2020 FY 2025
Free Cash Flow -37.8%
FY 2020 FY 2025
Financial Health
Current Ratio 3.6×
FY 2020 5y median 1.0× FY 2025
Quick Ratio 3.6×
FY 2020 5y median 1.0× FY 2025
Debt / Equity 0.4×
FY 2020 5y median 0.4× FY 2025
Net Debt / EBITDA 0.1×
FY 2020 5y median 0.1× FY 2025
Interest Coverage -81.6×
FY 2020 5y median -81.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31